Hadhami Ben Turkia

Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1

Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia et al. · JAMA · 2015 · 156 citations

Medicine, Hematology, Pharmacotherapy +11

Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trial

Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia et al. · American Journal of Hematology · 2017 · 99 citations · Full text

Medicine, Clinical Pharmacokinetics, Hematology +13

Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study

Derlis Gonzalez, Hadhami Ben Turkia, Elena Lukina et al. · American Journal of Hematology · 2012 · 87 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +15

Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease

Hadhami Ben Turkia, Derlis Gonzalez, Norman W. Barton et al. · American Journal of Hematology · 2012 · 70 citations · Full text

Medicine, Hematology, Pharmacotherapy +10

Incidence of mucopolysaccharidoses in Tunisia.

Hadhami Ben Turkia, Néji Tebib, Hatem Azzouz et al. · PubMed · 2009 · 42 citations

Life Sciences, Genetics, Pathology +12